Joon Cheol Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joon Cheol Park has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- Ae Ra Han
Daegu Cha Fertility Center, CHA University, Daegu 41936, Republic of Korea
2 shared publications Dong Ja Kim
Department of Forensic Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea; Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, South Korea
2 shared publications- Dong Ja Kim
Department of Forensic Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
2 shared publications - Jeong Ho Rhee
Department of Obstetrics and Gynecology, Keimyung University College of Medicine, Daegu, Korea
2 shared publications Jong In Kim
Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu, Korea
2 shared publications- Seul Ki Kim
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by The Korean Society for Medical Ethics in Korean Journal of Medical Ethics
- Vol. 29 (1) , 31-47
An Analysis of Judicial Precedents on Medical Practice in Criminal Litigation in Obstetrics and Gynecology
This study analyzed 22 criminal cases involving obstetricians and gynecologists to identify legal trends and propose measures to reduce the legal burden on medical professionals while maintaining stable healthcare services. The cases were retrieved from the Supreme Court of Korea Judicial Information Disclosure Portal using keywords such as “obstetrics,” “gynecology,” “expectant mother,” “fetus,” “neonate,” “delivery,” “uterus,” and “placenta.” The cases were classified into two categories: medical malpractice (16 cases, 72.7%) and abortion and bioethics (6 cases, 27.3%). Guilty verdicts were issued in 8 cases (36.4%), whereas 14 cases (63.6%) resulted in acquittal. The qualitative analysis showed that courts consistently protected physicians’ clinical discretion in unpredictable and unavoidable situations, such as amniotic fluid embolism and uterine atony, provided that standard medical protocols were followed. Procedural appropriateness, rather than the perfection of clinical outcomes, appeared to be the primary basis for judicial protection. Although the judiciary acknowledges the inherent limitations of medical practice and tends to protect physicians when established guidelines are followed, the high frequency of criminal prosecution remains a substantial burden on healthcare providers and may threaten the sustainability of obstetric care.
- 31 March 2026
- Published by The Korean Society for Medical Ethics in Korean Journal of Medical Ethics
- Vol. 29 (1) , 31-47
Open AccessAn Analysis of Judicial Precedents on Medical Practice in Criminal Litigation in Obstetrics and Gynecology
This study analyzed 22 criminal cases involving obstetricians and gynecologists to identify legal trends and propose measures to reduce the legal burden on medical professionals while maintaining stable healthcare services. The cases were retrieved from the Supreme Court of Korea Judicial Information Disclosure Portal using keywords such as “obstetrics,” “gynecology,” “expectant mother,” “fetus,” “neonate,” “delivery,” “uterus,” and “placenta.” The cases were classified into two categories: medical malpractice (16 cases, 72.7%) and abortion and bioethics (6 cases, 27.3%). Guilty verdicts were issued in 8 cases (36.4%), whereas 14 cases (63.6%) resulted in acquittal. The qualitative analysis showed that courts consistently protected physicians’ clinical discretion in unpredictable and unavoidable situations, such as amniotic fluid embolism and uterine atony, provided that standard medical protocols were followed. Procedural appropriateness, rather than the perfection of clinical outcomes, appeared to be the primary basis for judicial protection. Although the judiciary acknowledges the inherent limitations of medical practice and tends to protect physicians when established guidelines are followed, the high frequency of criminal prosecution remains a substantial burden on healthcare providers and may threaten the sustainability of obstetric care.
- Open Access
- 1 March 2025
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
- Vol. 52 (1) , 38-43
Assessment of anxiety, depression, and sexual dysfunction in women undergoing fertility treatment
Objective: Infertility and fertility treatment can lead to considerable physical, emotional, and psychological distress. These effects may be influenced by personality, familial bonds, and support systems within a sociocultural context. This preliminary investigation examined anxiety, depression, and sexual dysfunction in Korean women undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).Methods: Women scheduled for IVF/ICSI and healthy women seeking general health screening (controls) were enrolled. Participants were asked to complete standardized, validated questionnaires—the Hospital Anxiety and Depression Scale (HADS), Depression Anxiety and Stress Scale (DASS), and Female Sexual Function Index (FSFI)—to assess their levels of anxiety, depression, and sexual function. Results: The mean HADS scores for women undergoing IVF/ICSI were 6.35±3.48 (range, 0 to 13) for anxiety and 8.32±3.78 (range, 2 to 15) for depression. However, 12.9% of the women with infertility experienced clinically significant anxiety (HADS-Anxiety score >11), while 32.3% exhibited depression (HADS-Depression score >11). Based on DASS scores, psychological difficulties were more prevalent among women experiencing infertility than among control participants. Total FSFI scores, along with subscale ratings for desire, arousal, lubrication, satisfaction, and pain, were similar between women with infertility and control women. However, the mean score for orgasm was significantly lower in the infertility group (3.16) than among controls. Age, the durations of marriage and infertility, and parity did not significantly influence HADS, DASS, or FSFI scores.Conclusion: Anxiety and depression were more prevalent among women seeking fertility treatment than among healthy controls. Additionally, women with infertility may experience fewer or diminished orgasms.
- 1 March 2025
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
- Vol. 52 (1) , 38-43
Open AccessAssessment of anxiety, depression, and sexual dysfunction in women undergoing fertility treatment
Objective: Infertility and fertility treatment can lead to considerable physical, emotional, and psychological distress. These effects may be influenced by personality, familial bonds, and support systems within a sociocultural context. This preliminary investigation examined anxiety, depression, and sexual dysfunction in Korean women undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).Methods: Women scheduled for IVF/ICSI and healthy women seeking general health screening (controls) were enrolled. Participants were asked to complete standardized, validated questionnaires—the Hospital Anxiety and Depression Scale (HADS), Depression Anxiety and Stress Scale (DASS), and Female Sexual Function Index (FSFI)—to assess their levels of anxiety, depression, and sexual function. Results: The mean HADS scores for women undergoing IVF/ICSI were 6.35±3.48 (range, 0 to 13) for anxiety and 8.32±3.78 (range, 2 to 15) for depression. However, 12.9% of the women with infertility experienced clinically significant anxiety (HADS-Anxiety score >11), while 32.3% exhibited depression (HADS-Depression score >11). Based on DASS scores, psychological difficulties were more prevalent among women experiencing infertility than among control participants. Total FSFI scores, along with subscale ratings for desire, arousal, lubrication, satisfaction, and pain, were similar between women with infertility and control women. However, the mean score for orgasm was significantly lower in the infertility group (3.16) than among controls. Age, the durations of marriage and infertility, and parity did not significantly influence HADS, DASS, or FSFI scores.Conclusion: Anxiety and depression were more prevalent among women seeking fertility treatment than among healthy controls. Additionally, women with infertility may experience fewer or diminished orgasms.
- 8 July 2022
- Published by Elsevier
List of contributors
- Open Access
- 1 March 2022
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 04 (01) , 32-35
Atypical Swyer Syndrome Presenting with Spontaneous Breast Development and Secondary Amenorrhea
- 1 March 2022
- Published by World Scientific Pub Co Pte Ltd in Fertility & Reproduction
- Vol. 04 (01) , 32-35
Open AccessAtypical Swyer Syndrome Presenting with Spontaneous Breast Development and Secondary Amenorrhea
- Open Access
- 1 March 2022
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
- Vol. 49 (1) , 2-8
Effects and safety of COVID-19 vaccination on assisted reproductive technology and pregnancy: A comprehensive review and joint statements of the KSRM, the KSRI, and the KOSAR
Humanity is in the midst of the coronavirus disease 2019 (COVID-19) pandemic, and vaccines—including mRNA vaccines—have been developed at an unprecedented speed. It is necessary to develop guidelines for vaccination for people undergoing treatment with assisted reproductive technology (ART) and for pregnancy-related situations based on the extant laboratory and clinical data. COVID-19 vaccines do not appear to adversely affect gametes, embryos, or implantation; therefore, active vaccination is recommended for women or men who are preparing for ART. The use of intravenous immunoglobulin G (IVIG) for the treatment of immune-related infertility is unlikely to impact the effectiveness of the vaccines, so COVID-19 vaccines can be administered around ART cycles in which IVIG is scheduled. Pregnant women have been proven to be at risk of severe maternal and neonatal complications from COVID-19. It does not appear that COVID-19 vaccines harm pregnant women or fetuses; instead, they have been observed to deliver antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to the fetus. Accordingly, it is recommended that pregnant women receive COVID-19 vaccination. There is no rationale for adverse effects, or clinical cases of adverse reactions, in mothers or neonates after COVID-19 vaccination in lactating women. Instead, antibodies to SARS-CoV-2 can be delivered through breast milk. Therefore, breastfeeding mothers should consider vaccination. In summary, active administration of COVID-19 vaccines will help ensure the safe implementation of ART, pregnancy, and breastfeeding.
- 1 March 2022
- Published by The Korean Society for Reproductive Medicine in Clinical and Experimental Reproductive Medicine
- Vol. 49 (1) , 2-8
Open AccessEffects and safety of COVID-19 vaccination on assisted reproductive technology and pregnancy: A comprehensive review and joint statements of the KSRM, the KSRI, and the KOSAR
Humanity is in the midst of the coronavirus disease 2019 (COVID-19) pandemic, and vaccines—including mRNA vaccines—have been developed at an unprecedented speed. It is necessary to develop guidelines for vaccination for people undergoing treatment with assisted reproductive technology (ART) and for pregnancy-related situations based on the extant laboratory and clinical data. COVID-19 vaccines do not appear to adversely affect gametes, embryos, or implantation; therefore, active vaccination is recommended for women or men who are preparing for ART. The use of intravenous immunoglobulin G (IVIG) for the treatment of immune-related infertility is unlikely to impact the effectiveness of the vaccines, so COVID-19 vaccines can be administered around ART cycles in which IVIG is scheduled. Pregnant women have been proven to be at risk of severe maternal and neonatal complications from COVID-19. It does not appear that COVID-19 vaccines harm pregnant women or fetuses; instead, they have been observed to deliver antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to the fetus. Accordingly, it is recommended that pregnant women receive COVID-19 vaccination. There is no rationale for adverse effects, or clinical cases of adverse reactions, in mothers or neonates after COVID-19 vaccination in lactating women. Instead, antibodies to SARS-CoV-2 can be delivered through breast milk. Therefore, breastfeeding mothers should consider vaccination. In summary, active administration of COVID-19 vaccines will help ensure the safe implementation of ART, pregnancy, and breastfeeding.
- Open Access
- 31 July 2021
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 38 (3) , 235-239
Successful laparoscopic surgery of accessory cavitated uterine mass in young women with severe dysmenorrhea
Accessory cavitated uterine mass (ACUM) is a rare and unique condition seen in young women. We report cases of ACUMs in two patients, a 14-year-old girl and a 25-year-old woman, both with complaints of severe dysmenorrhea that had started at menarche and had progressively worsened since. A large cystic lesion was localized in the anterolateral wall of the myometrium separate from the endometrium, which was difficult to distinguish from congenital uterine anomalies. Laparoscopic excision of the ACUMs was successful and completely resolved the dysmenorrhea. Early investigation of severe dysmenorrhea in young women can provide appropriate management and relieve symptoms.
- 31 July 2021
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 38 (3) , 235-239
Open AccessSuccessful laparoscopic surgery of accessory cavitated uterine mass in young women with severe dysmenorrhea
Accessory cavitated uterine mass (ACUM) is a rare and unique condition seen in young women. We report cases of ACUMs in two patients, a 14-year-old girl and a 25-year-old woman, both with complaints of severe dysmenorrhea that had started at menarche and had progressively worsened since. A large cystic lesion was localized in the anterolateral wall of the myometrium separate from the endometrium, which was difficult to distinguish from congenital uterine anomalies. Laparoscopic excision of the ACUMs was successful and completely resolved the dysmenorrhea. Early investigation of severe dysmenorrhea in young women can provide appropriate management and relieve symptoms.
- Open Access
- 15 June 2020
- Published by Keimyung University School of Medicine in Keimyung Medical Journal
- Vol. 39 (1) , 38-42
Influence of Human PapillomaVirus Infection Detected by Cervical Swap on In-vitro Fertilization Outcomes
Human papilloma virus (HPV) infection had been suspected of harmful effect on reproduction by increasing blastocyst apoptosis and reducing the endometrial implantation of trophoblastic cells. However, the available evidence is conflicting concerning the impact of HPV in female reproductive system on the outcome of in-vitro fertilization (IVF) The aim of study was to evaluate IVF outcomes regarding the cervical HPV infection. Retrospective case-control study conducted in women suffered IVF cycle. All women were evaluated the HPV infection using PCR by cervical swap before the initiation of IVF cycle. One hundred thirty six cycles were evaluated. The harvested oocytes number, top quality embryo number, fertilization rate, implantation rate, clinical pregnancy rate, live birth rate and miscarriage rate were analyzed depend on HPV infection. Mean age of enrolled women was 35.20±4.79 years-old, mean parity was 0.17±0.57, and mean number of miscarriage was 0.81±1.49. Basal FSH was 5.42±2.59 IU/L and AMH level was 5.07±11.01 ng/ mL, which was not different between two groups. Mean harvested oocytes was 6.36±4.32 in HPV infected women compared with 8.63±5.95 in women without infection, statistically insignificant. Top quality embryos of each group were not different (2.67±0.82, 2.53±1.53 separately). In women with HPV infection, ongoing pregnancy rate (27.3%) and live birth rate (18.2%) were similar with women without infection (23.7%, 14.0%). And also, fertilization rate and implantation rate were similar. Miscarriage rate of each group was 33.3%, and 40.7%, which was statistically insignificant. The HPV infection in women did not make the adverse influence on IVF outcomes.
- 15 June 2020
- Published by Keimyung University School of Medicine in Keimyung Medical Journal
- Vol. 39 (1) , 38-42
Open AccessInfluence of Human PapillomaVirus Infection Detected by Cervical Swap on In-vitro Fertilization Outcomes
Human papilloma virus (HPV) infection had been suspected of harmful effect on reproduction by increasing blastocyst apoptosis and reducing the endometrial implantation of trophoblastic cells. However, the available evidence is conflicting concerning the impact of HPV in female reproductive system on the outcome of in-vitro fertilization (IVF) The aim of study was to evaluate IVF outcomes regarding the cervical HPV infection. Retrospective case-control study conducted in women suffered IVF cycle. All women were evaluated the HPV infection using PCR by cervical swap before the initiation of IVF cycle. One hundred thirty six cycles were evaluated. The harvested oocytes number, top quality embryo number, fertilization rate, implantation rate, clinical pregnancy rate, live birth rate and miscarriage rate were analyzed depend on HPV infection. Mean age of enrolled women was 35.20±4.79 years-old, mean parity was 0.17±0.57, and mean number of miscarriage was 0.81±1.49. Basal FSH was 5.42±2.59 IU/L and AMH level was 5.07±11.01 ng/ mL, which was not different between two groups. Mean harvested oocytes was 6.36±4.32 in HPV infected women compared with 8.63±5.95 in women without infection, statistically insignificant. Top quality embryos of each group were not different (2.67±0.82, 2.53±1.53 separately). In women with HPV infection, ongoing pregnancy rate (27.3%) and live birth rate (18.2%) were similar with women without infection (23.7%, 14.0%). And also, fertilization rate and implantation rate were similar. Miscarriage rate of each group was 33.3%, and 40.7%, which was statistically insignificant. The HPV infection in women did not make the adverse influence on IVF outcomes.
- Open Access
- 1 January 2020
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (10) , 868-874
A New Thermo-Responsive Hyaluronic Acid Sol-Gel to Prevent Intrauterine Adhesions after Hysteroscopic Surgery: A Randomized, Non-Inferiority Trial
Lee DY, et al. Yonsei Med J. 2020 Oct;61(10):868-874. https://doi.org/10.3349/ymj.2020.61.10.868
- 1 January 2020
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (10) , 868-874
Open AccessA New Thermo-Responsive Hyaluronic Acid Sol-Gel to Prevent Intrauterine Adhesions after Hysteroscopic Surgery: A Randomized, Non-Inferiority Trial
Lee DY, et al. Yonsei Med J. 2020 Oct;61(10):868-874. https://doi.org/10.3349/ymj.2020.61.10.868
- Open Access
- 1 January 2016
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 59 (5) , 379-387
Etiologic characteristics and index pregnancy outcomes of recurrent pregnancy losses in Korean women
Lee GS, et al. Obstet Gynecol Sci. 2016 Sep;59(5):379-387. https://doi.org/10.5468/ogs.2016.59.5.379
- 1 January 2016
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 59 (5) , 379-387
Open AccessEtiologic characteristics and index pregnancy outcomes of recurrent pregnancy losses in Korean women
Lee GS, et al. Obstet Gynecol Sci. 2016 Sep;59(5):379-387. https://doi.org/10.5468/ogs.2016.59.5.379